Juan Andres - Mar 16, 2022 Form 4 Insider Report for Moderna, Inc. (MRNA)

Role
Chief Technical Operations and Quality Officer
Signature
/s/ Brian Sandstrom, as Attorney-in-Fact
Stock symbol
MRNA
Transactions as of
Mar 16, 2022
Transactions value $
-$271,580
Form type
4
Date filed
3/18/2022, 04:09 PM
Previous filing
Mar 15, 2022
Next filing
Mar 25, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRNA Common Stock Options Exercise $28.4K +2K +22.05% $14.22* 11.1K Mar 16, 2022 Direct F1
transaction MRNA Common Stock Sale -$300K -2K -18.07% $150.01 9.07K Mar 16, 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRNA Stock Option (Right to Buy) Options Exercise $0 -2K -12.03% $0.00 14.6K Mar 16, 2022 Common Stock 2K $14.22 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on November 19, 2021.
F2 This option is fully vested and exercisable.

Remarks:

Chief Technical Operations and Quality Officer